Jennifer A Brown
jenniferannebrown.bsky.social
Jennifer A Brown
@jenniferannebrown.bsky.social
Clinical Epidemiology | Randomised Clinical Trials | Causal Inference | HIV Research
Reposted by Jennifer A Brown
Uptake and 24-month outcomes of dolutegravir- versus lopinavir-based second-line antiretroviral therapy for people with HIV in South Africa

✅ Just Accepted
✍️ @jenniferannebrown.bsky.social @oxprimarycare.bsky.social
#IDSky
Uptake and 24-month outcomes of dolutegravir- versus lopinavir-based second-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study and emulated target trial
A target trial emulation including adults switched from TDF/XTC/EFV to second-line AZT/XTC/LPV/r, AZT/XTC/DTG, or TDF/XTC/DTG in a South African HIV cohort...
bit.ly
September 5, 2025 at 10:37 PM
Reposted by Jennifer A Brown
💇🏾‍♀️ New publication from our team: Hair Salons as a promising space to provide HIV & Sexual and SRH services for young women in Lesotho

💭 The team is currently looking for funding to implement a pilot - ideas welcome!

Read more here: bmcpublichealth.biomedcentral.com/articles/10....
Hair salons as a promising space to provide HIV and sexual and reproductive health services for young women in Lesotho: a citizen scientist mixed-methods study - BMC Public Health
Introduction Adolescent girls and young women in southern Africa are disproportionately affected by HIV and sexual and reproductive health (SRH) challenges. There is a need for more accessible and de-...
bmcpublichealth.biomedcentral.com
July 8, 2025 at 7:11 PM
Reposted by Jennifer A Brown